Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rayonier Advanced Materials (RYAM) Capital Expenditures (2016 - 2025)

Rayonier Advanced Materials' Capital Expenditures history spans 13 years, with the latest figure at -$69.2 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 344.79% year-over-year to -$69.2 million; the TTM value through Dec 2025 reached $29.4 million, down 72.72%, while the annual FY2025 figure was $29.4 million, 72.72% down from the prior year.
  • Capital Expenditures reached -$69.2 million in Q4 2025 per RYAM's latest filing, down from $68.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $121.9 million in Q4 2022 to a low of -$70.3 million in Q3 2022.
  • Average Capital Expenditures over 5 years is $24.8 million, with a median of $30.5 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: soared 369.93% in 2021, then plummeted 602.63% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $32.2 million in 2021, then surged by 278.73% to $121.9 million in 2022, then plummeted by 73.37% to $32.5 million in 2023, then decreased by 12.9% to $28.3 million in 2024, then plummeted by 344.79% to -$69.2 million in 2025.
  • Per Business Quant, the three most recent readings for RYAM's Capital Expenditures are -$69.2 million (Q4 2025), $68.8 million (Q3 2025), and -$7.7 million (Q2 2025).